Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial

Authors

Federica Malinverno
Sergio Malandrin
Cesare Maino (ORCID: https://orcid.org/0000-0002-5742-802X)
Stefania Galimberti (ORCID: https://orcid.org/0000-0003-1504-7242)
A. Gerussi
Federica Facciotti (ORCID: https://orcid.org/0000-0002-2541-9428)
Pietro Tettamanti
P. Invernizzi
L. Cristoferi
D. Bernasconi
Marco Dinelli (ORCID: https://orcid.org/0000-0003-0214-0333)
Rocco Corso
Marco Carbone
Marco Mario Festa
Davide Ippolito
Emanuela Rossi

Institutions

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
Azienda Ospedaliera San Gerardo (IT)
University of Milano-Bicocca (IT)

Publication Details

Journal: BMJ Open
Published: 2026-01-01
DOI: https://doi.org/10.1136/bmjopen-2025-106630
Primary Topic: Liver Diseases and Immunity
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Università degli Studi di Milano-Bicocca
American Medical Association Foundation

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial

Federica Malinverno, Sergio Malandrin, Cesare Maino, Stefania Galimberti et al.

Jan 1, 2026

BMJ Open

Liver Diseases and Immunity

article

Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial

Federica Malinverno, Sergio Malandrin, Cesare Maino, Stefania Galimberti, A. Gerussi, Federica Facciotti, Pietro Tettamanti, P. Invernizzi, L. Cristoferi, D. Bernasconi, Marco Dinelli, Rocco Corso, Marco Carbone, Marco Mario Festa, Davide Ippolito, Emanuela Rossi

January 1, 2026article en

Abstract

No abstract available for this paper.

BMJ OpenVol. 16(1)

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT), Azienda Ospedaliera San Gerardo (IT), University of Milano-Bicocca (IT)

Università degli Studi di Milano-Bicocca, American Medical Association Foundation

Good health and well-being

Openalex Percentile: Top 93%

Liver Diseases and Immunity

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial — Federica Malinverno, Sergio Malandrin, et al. · BMJ Open (2026) | TGRS Research Map | TGRS